
7年随访结果显示,23价肺炎球菌多糖疫苗并未显著预防心血管事件
一项大型随机临床试验表明,23价肺炎球菌多糖疫苗(PPV23)在7年的随访期内,并未显著减少中年心血管风险增加成人中的致命或非致命急性冠状动脉综合征和缺血性卒中。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.